The 2 Minute Medicine® Podcast

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH”. In the second half of our episode, we begin by exploring the recently announced price drop for a popular tuberculosis test. Then we discuss Sufjan Stevens' ongoing battle with the rare autoimmune condition, Guillain-Barre Syndrome. Finally, we end with a conversation about newly developed tests to identify medical abortions and the ongoing American Red Cross blood supply shortage. 

We begin this episode by discussing our article of the week from JAMA Network Open, entitled “Women’s Adherence to Healthy Dietary Patterns and Outcomes of Infertility Treatment”. In the second half of our episode, we begin with a discussion about Shohei Ohtani, the superstar baseball player fighting against a torn ligament. Next, we look at blue light glasses, an increasingly popular way to combat eye strain in the digital world. After that, we discuss sciatica, and how this disease affects the lives of many, including some famous names. Finally, we discuss the long-term and short-term impacts of concussion and CTE.

We begin this episode by discussing our article of the week from the Lancet “Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA”. In the second half of our episode, we begin with a discussion of Wegovy and the latest data on its human use. Next, we discuss congenital heart disease in sports. Following that, we examine the latest developments with the COVID-19 virus, and last but not least, we examine the recent news about long-lasting chemicals found in paper straws, and their impact on human health.

We begin this episode by discussing our article of the week from from the New England Journal of Medicine, entitled “Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.” In the second half, we have a conversation about Alzheimer's disease and how a drug called Donanemab has shown a 29% slower rate of decline and cognitive function. Next, we look at complications of bariatric surgery, the medical effects of heat exhaustion and what we can do to prevent it, and conclude with a conversation about energy drinks and it's lesser known side effects.

We begin this episode by discussing our article of the week from JAMA and is entitled, “Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021. In the second half of our episode, we begin by discussing the FIFA Women's World Cup and some of the strides taken to protect and support female athletes. Then we discuss National Immunization Awareness Month and some health tips for heading back-to-school. Finally, we conclude with a discussion on Overdose Awareness Day and the importance of naloxone in preventing deaths due to overdose.

We begin this episode by discussing our article of the week from BMC medicine, “Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial”. In the second half of our episode, we begin with a discussion about a blood test that was recently approved by the federal drug administration that can detect those at a greater risk for pre-eclampsia. Then we discuss the American Medical Association's new policy regarding the use of BMI in medical practice. Finally, we end with a conversation about Madonna's recent sepsis scare, as well as some of the injuries seen in the latest edition of the Tour de France.

We begin this episode by discussing our article of the week from the New England Journal of Medicine entitled “Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.”In the second half of our episode, we begin with a discussion about how the Supreme Court of the United States may impact college admissions for the foreseeable future. Then we explore the latest information regarding the link between a beloved artificial sweetener, and cancer. Last, but not least, we have a conversation about blood clots along with the stars who have experienced them, and psychedelics, a class of drugs recently approved for mental health treatment in Australia!

We begin this episode by discussing our article of the week from the New England Journal of Medicine entitled “Hydrocortisone in severe community-acquired pneumonia.“. In the second half of our episode, we bring a medical eye to popular events. We begin with a discussion about how the federal drug administration recently approved a drug to treat some symptoms of menopause. Then we take a closer look at the affordable care act mandate for preventative care. Last, but not least, we have a conversation about pride month and inequalities that exist in the healthcare system for the LGBTQ+ community and Nirsevimab, an antibody that can help prevent severe symptoms of RSV in infants!

We begin this episode by discussing our article of the week comes from the New England Journal of Medicine and is entitled “Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy“. In the second half of our episode, we bring a medical eye to popular events. We begin a discussion about antibiotic resistance, and how a team from McMaster University decided to leverage a powerful tool in their arsenal of antibiotic discovery, artificial intelligence. Next, we discuss how Melissa Gilbert, known for her role in “Little House on the Prairie”, experienced a bug bite that led to an emergency room visit and overnight hospitalization. We conclude by taking a closer look at why Canada is printing health warnings on individual cigarettes and a conversation about the importance of CPR. 

Welcome to the 2 Minute Medicine® Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. For the full transcript of this episode and more, please visit our website at https://www.2minutemedicine.com/the-2-minute-medicine-podcast-episode-15/ We begin this episode by discussing our article of the week which comes from  Our article of the week comes from The Lancet and is entitled “Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.” (01:24) First article of the week.  In the second half of our episode, we bring a medical eye to popular events. First, we take a closer look at how the FDA has recommended making a hormonal contraceptive pill, Opill, available over the counter. We then have a conversation about the recent pancreatic cancer vaccine trial, delving deeper into the subject of cancer immunotherapy. We conclude with a conversation about how Montana has become the first state to fully ban TikTok. We discuss the implications of social media on mental health, specifically among teenagers. (04:00) OTC Birth Control (06:51) Pancreatic Cancer Vaccine (08:53) Montana's ban on TikTok Please head to our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series which is available on Amazon, and The Scan, which is our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed!